W
Walter Berger
Researcher at Medical University of Vienna
Publications - 396
Citations - 16667
Walter Berger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Cancer & Cell culture. The author has an hindex of 63, co-authored 359 publications receiving 14045 citations. Previous affiliations of Walter Berger include University of Vienna & Université libre de Bruxelles.
Papers
More filters
Patent
Combination therapy using a ruthenium complex
TL;DR: In this article, a combination therapy for treating cancer is described, which comprises administering to a cancer patient a therapeutically effective amount of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] or a pharmaceutically acceptable salt thereof.
Journal ArticleDOI
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.
Friedrich Erhart,Tamara Weiss,Simone Klingenbrunner,Katrin Fischhuber,René Reitermaier,Angela Halfmann,Bernadette Blauensteiner,Daniela Lötsch,Sabine Spiegl-Kreinecker,Walter Berger,Fernando J. Sialana,Gert Lubec,Thomas Felzmann,Alexander M. Dohnal,Carmen Visus +14 more
TL;DR: Spheroidculture proteins seem to represent survival-relevant targets, supporting the use of spheroid culture conditions as an antigen source for DC immunotherapy, and immunogenicity enhancement should be considered for future research.
Journal ArticleDOI
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness
Lisa Gabler,C. Jaunecker,Sonja Katz,Sushilla van Schoonhoven,Bernhard Englinger,Christine Pirker,Thomas Mohr,Petra Vician,Mirjana Stojanovic,Valentin Woitzuck,Anna Laemmerer,Dominik Kirchhofer,Lisa Mayr,M. LaFranca,Friedrich Erhart,Sarah Grissenberger,Andrea Wenninger-Weinzierl,Caterina Sturtzel,Barbara Kiesel,Alexandra Lang,Brigitte Marian,Bettina Grasl-Kraupp,Martin Distel,Julia Schüler,Johannes Gojo,Michael Grusch,Sabine Spiegl-Kreinecker,Daniel J. Donoghue,Daniela Lötsch,Walter Berger +29 more
TL;DR: In this paper , an extended panel of primary surgical specimen-derived and immortalized GBM (stem)cell models and original tumor tissues were screened for FGFR4 expression and showed that dominant negative FGFR 4 overexpression resulted in diminished (subcutaneous) or blocked (orthotopic) GBM xenograft formation in the mouse and reduced invasiveness in zebrafish xenotransplantation models.
Journal Article
Relevance of microRNA modulation in chemoresistant colon cancer in vitro.
Robert M. Mader,Matthias Wieser,Walter Berger,Maria Kalipciyan,Matthias Hackl,Günther G. Steger,Johannes Grillari +6 more
Journal ArticleDOI
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness
Lisa Gabler,C. Jaunecker,Sonja Katz,Sushilla van Schoonhoven,Bernhard Englinger,Christine Pirker,Thomas Mohr,Petra Vician,Mirjana Stojanovic,Valentin Woitzuck,Anna Laemmerer,Dominik Kirchhofer,Lisa Mayr,M. LaFranca,Friedrich Erhart,Sarah Grissenberger,Andrea Wenninger-Weinzierl,Caterina Sturtzel,Barbara Kiesel,Alexandra Lang,Brigitte Marian,Bettina Grasl-Kraupp,Martin Distel,Julia Schüler,Johannes Gojo,Michael Grusch,Sabine Spiegl-Kreinecker,Daniel J. Donoghue,Daniela Lötsch,Walter Berger +29 more
TL;DR: In this paper , an extended panel of primary surgical specimen-derived and immortalized GBM (stem)cell models and original tumor tissues were screened for FGFR4 expression and showed that dominant negative FGFR 4 overexpression resulted in diminished (subcutaneous) or blocked (orthotopic) GBM xenograft formation in the mouse and reduced invasiveness in zebrafish xenotransplantation models.